Australia, New Zealand Thalidomide Suit Settled For U.S.$81.5 Million
This article was originally published in PharmAsia News
Executive Summary
A class-action suit involving treatments of Australia and New Zealand patients with thalidomide half a century ago has been settled in an Australian court by the distributor for U.S.$81.5 million.